Surgical complications of salvage total laryngectomy following concurrent chemoradiotherapy

被引:64
作者
Furuta, Yasushi [1 ]
Homma, Akihiro [1 ]
Oridate, Nobuhiko [1 ]
Suzuki, Fumiyuki [1 ]
Hatakeyama, Hiromitsu [1 ]
Suzuki, Keishiro [2 ]
Nishioka, Takeshi [2 ]
Shirato, Hiroki [2 ]
Fukuda, Satoshi [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Radiol, Sapporo, Hokkaido, Japan
关键词
Chemoradiotherapy; Laryngeal cancer; Total laryngectomy; Wound complications; Fistula;
D O I
10.1007/s10147-008-0787-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surgical complication rates of total laryngectomy vary according to the preoperative treatments performed and patient factors. Wound complications after salvage laryngectomy following concurrent chemoradiotherapy (CCRT) were analyzed. Eighty-six patients who had undergone total laryngectomy for laryngeal cancer at Hokkaido University Hospital, Japan, between 1990 and 2006 were divided into three groups according to preoperative treatments received: group I (n = 35) without radiotherapy (RT) or CCRT, group II (n = 17) RT alone, and group III (n = 34) low-dose CCRT. Salvage total laryngectomy was performed as a consequence of residual or recurrent disease after completion of the treatments. Wound complications such as pharyngocutaneous fistulas, bleeding, infections, and skin necrosis were retrospectively analyzed in each group. A considerable (not statistically significant) difference in the incidence of major wound complications was observed between groups I and III (11.4% vs 29.4%, P = 0.078), but not between groups II and III. In stage III/IV patients, a significant increase in the incidence of wound complications was observed in group III compared to group I. Pharyngocutaneous fistulas were the most common complication, occurring in 8/34 (23.5%) of the group III patients. Additional pharyngeal reconstruction surgery was performed in 5 of the 8 (62.5%) group III patients with pha ryngocutaneous fistulas, while no such patients (0/3) in group I required reconstruction surgery. There was an increased risk of wound complications in patients undergoing salvage laryngectomy following CCRT. Patients who developed pharyngocutaneous fistulas after CCRT tended to require surgical reintervention for repair. These findings should be taken into account before the initiation of CCRT and salvage surgery.
引用
收藏
页码:521 / 527
页数:7
相关论文
共 19 条
[1]  
COREY JP, 1986, ARCH OTOLARYNGOL, V112, P437
[2]  
*DEP VET AFF LAR C, 2003, NEW ENGL J MED, V324, P1685
[3]   Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer [J].
Forastiere, AA ;
Goepfert, H ;
Maor, M ;
Pajak, TF ;
Weber, R ;
Morrison, W ;
Glisson, B ;
Trotti, A ;
Ridge, JA ;
Chao, C ;
Peters, G ;
Lee, DJ ;
Leaf, A ;
Ensley, J ;
Cooper, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2091-2098
[4]   Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck [J].
Fujii M. ;
Tsukuda M. ;
Satake B. ;
Kubota A. ;
Kida A. ;
Kohno N. ;
Okami K. ;
Inuyama Y. .
International Journal of Clinical Oncology, 2004, 9 (2) :107-112
[5]   Prevention of wound complications following salvage laryngectomy using free vascularized tissue [J].
Fung, Kevin ;
Teknos, Theodoros N. ;
Vandenberg, Curtis D. ;
Lyden, Teresa H. ;
Bradford, Carol R. ;
Hogikyan, Norman D. ;
Kim, Jennifer ;
Prince, Mark E. P. ;
Wolf, Gregory T. ;
Chepeha, Douglas B. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (05) :425-430
[6]   Postoperative complications of salvage total laryngectomy [J].
Ganly, I ;
Patel, S ;
Matsuo, J ;
Singh, B ;
Kraus, D ;
Boyle, J ;
Wong, R ;
Lee, N ;
Pfister, DG ;
Shaha, A ;
Shah, J .
CANCER, 2005, 103 (10) :2073-2081
[7]   Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means? [J].
Goodwin, WJ .
LARYNGOSCOPE, 2000, 110 (03) :1-18
[8]   Randomized phase II trial of concomitant chemoradiotherapy using weekly carboplatin or daily low-dose cisplatin for squamous cell carcinoma of the head and neck [J].
Homma, A ;
Shirato, H ;
Furuta, Y ;
Nishioka, T ;
Oridate, N ;
Tsuchiya, K ;
Nagahashi, T ;
Aoyama, H ;
Inuyama, Y ;
Fukuda, S .
CANCER JOURNAL, 2004, 10 (05) :326-332
[9]   PREVENTION OF MAJOR AND MINOR FISTULAS AFTER LARYNGECTOMY [J].
HORGAN, EC ;
DEDO, HH .
LARYNGOSCOPE, 1979, 89 (02) :250-260
[10]   Retrospective analysis: Concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer [J].
Itoh Y. ;
Fuwa N. .
Radiation Medicine, 2006, 24 (4) :277-281